CSPC Pharmaceutical Group Limited (CSPCY)
Company Info
Highlights
$10.05B
$0.20
17.30
8.92
$16.28B
$11.65B
$4.25B
$2.23 - $3.82
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
CSPC Pharmaceutical Group Limited (CSPCY) returned 51.16% year-to-date (YTD) and 13.14% over the past 12 months.
CSPCY
51.16%
20.39%
39.69%
13.14%
2.29%
1.12%
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of CSPCY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -6.95% | 5.81% | 4.83% | 24.49% | 17.65% | 51.16% | |||||||
| 2024 | -21.03% | 6.47% | 0.51% | 5.44% | 2.29% | -3.96% | -6.49% | -17.05% | 26.05% | -5.07% | -9.38% | -5.56% | -30.47% |
| 2023 | 8.54% | -5.83% | -8.43% | 3.35% | -14.29% | 1.38% | -4.23% | -9.58% | -0.19% | 19.10% | 3.41% | 2.99% | -7.84% |
| 2022 | 11.55% | -2.33% | -2.39% | -10.67% | 4.98% | -7.28% | 10.22% | -6.97% | -1.40% | 3.74% | 24.51% | -17.91% | -0.87% |
| 2021 | 10.41% | 0.23% | 11.45% | 2.44% | 22.28% | -3.66% | -6.82% | -5.90% | -4.67% | -12.77% | -0.95% | 4.82% | 12.67% |
| 2020 | 0.60% | -5.28% | -9.33% | -1.21% | -3.95% | -4.05% | 32.86% | 6.81% | -12.14% | -45.96% | 61.97% | -6.67% | -19.90% |
| 2019 | 0.00% | -16.15% | 22.35% | -0.39% | 25.78% | -11.45% | 5.06% | 19.57% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CSPCY is 63, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for CSPC Pharmaceutical Group Limited (CSPCY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
CSPC Pharmaceutical Group Limited provided a 4.14% dividend yield over the last twelve months, with an annual payout of $0.15 per share. The company has been increasing its dividends for 5 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.15 | $0.15 | $0.13 | $0.10 | $0.09 | $0.07 | $0.05 |
Dividend yield | 4.14% | 6.26% | 3.41% | 2.43% | 2.00% | 1.86% | 0.96% |
Monthly Dividends
The table displays the monthly dividend distributions for CSPC Pharmaceutical Group Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.15 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.13 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.10 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.09 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | $0.07 |
| 2019 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 |
Dividend Yield & Payout
Dividend Yield
CSPC Pharmaceutical Group Limited has a dividend yield of 4.14%, which is quite average when compared to the overall market.
Payout Ratio
CSPC Pharmaceutical Group Limited has a payout ratio of 74.14%, which is quite average when compared to the overall market. This suggests that CSPC Pharmaceutical Group Limited strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the CSPC Pharmaceutical Group Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CSPC Pharmaceutical Group Limited was 60.74%, occurring on Jan 15, 2025. The portfolio has not yet recovered.
The current CSPC Pharmaceutical Group Limited drawdown is 34.49%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -60.74% | Jun 14, 2021 | 903 | Jan 15, 2025 | — | — | — |
| -53.27% | Oct 23, 2020 | 2 | Oct 27, 2020 | 63 | May 14, 2021 | 65 |
| -32.74% | Nov 15, 2019 | 16 | Mar 23, 2020 | 34 | Oct 19, 2020 | 50 |
| -23.75% | Jul 1, 2019 | 7 | Aug 15, 2019 | 2 | Aug 23, 2019 | 9 |
| -2.86% | May 28, 2021 | 1 | May 28, 2021 | 1 | Jun 1, 2021 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CSPC Pharmaceutical Group Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of CSPC Pharmaceutical Group Limited, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how CSPC Pharmaceutical Group Limited is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CSPCY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, CSPCY has a P/E ratio of 17.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CSPCY compared to other companies in the Drug Manufacturers - General industry. CSPCY currently has a PEG ratio of 8.9. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CSPCY relative to other companies in the Drug Manufacturers - General industry. Currently, CSPCY has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CSPCY in comparison with other companies in the Drug Manufacturers - General industry. Currently, CSPCY has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |